Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Nuala McNicholas, Niall Tubridy, Michael Hutchinson, Chris McGuiga. Perceived and objective cognitive impairment in newly diagnosed versus established multiple sclerosis: impact of disease duration. Irish journal of medical science. vol 190. issue 3. 2021-10-04. PMID:33108620. |
cognitive impairment (ci) is common in multiple sclerosis (ms), including newly diagnosed ms, where it is particularly underrecognised. |
2021-10-04 |
2023-08-13 |
Not clear |
Yixuan Ye, Hongxi Yang, Yaogang Wang, Hongyu Zha. A comprehensive genetic and epidemiological association analysis of vitamin D with common diseases/traits in the UK Biobank. Genetic epidemiology. vol 45. issue 1. 2021-09-13. PMID:32918767. |
in mr-analysis, we presented evidence suggesting potential causal role of 25(oh)d in increasing height (β = .064, 95% confidence interval [ci] = 0.019-0.11) and preventing the risk of ovarian cancer (odds ratio [or] = 0.96, 95% ci = 0.93-0.99), multiple sclerosis (or = 0.96, 95% ci = 0.94-0.98), leg fracture (or = 0.60, 95% ci = 0.45-0.80) and femur fracture (or = 0.53, 95% ci = 0.32-0.84). |
2021-09-13 |
2023-08-13 |
human |
Xia Jiang, Tian Ge, Chia-Yen Che. The causal role of circulating vitamin D concentrations in human complex traits and diseases: a large-scale Mendelian randomization study. Scientific reports. vol 11. issue 1. 2021-08-09. PMID:33420236. |
consistent with previous findings, genetically predicted increased 25(oh)d levels significantly decreased the risk of multiple sclerosis (or = 0.824; 95% ci 0.689-0.986). |
2021-08-09 |
2023-08-13 |
human |
Jian Zhang, Rosa Cortese, Nicola De Stefano, Antonio Giorgi. Structural and Functional Connectivity Substrates of Cognitive Impairment in Multiple Sclerosis. Frontiers in neurology. vol 12. 2021-07-27. PMID:34305785. |
cognitive impairment (ci) occurs in 43 to 70% of multiple sclerosis (ms) patients at both early and later disease stages. |
2021-07-27 |
2023-08-13 |
Not clear |
Nuala McNicholas, Audrey Russell, Geraldine Nolan, Niall Tubridy, Michael Hutchinson, John Francis Garvey, Christopher McGuiga. Impact of obstructive sleep apnoea on cognitive function in multiple sclerosis: A longitudinal study. Journal of sleep research. vol 30. issue 3. 2021-07-15. PMID:32791570. |
cognitive impairment (ci) and fatigue are common in people with multiple sclerosis (ms), with well-known profound effects on quality of life. |
2021-07-15 |
2023-08-13 |
human |
Marco Pitteri, Ilaria Boscolo Galazzo, Lorenza Brusini, Federica Cruciani, Caterina Dapor, Damiano Marastoni, Gloria Menegaz, Massimiliano Calabres. Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter. Diagnostics (Basel, Switzerland). vol 11. issue 6. 2021-07-05. PMID:34208650. |
although cognitive impairment (ci) is frequently observed in people with multiple sclerosis (pwms), its pathogenesis is still controversial. |
2021-07-05 |
2023-08-13 |
human |
Whitney M Freeze, Merel van der Thiel, Jeroen de Bresser, Catharina J M Klijn, Ellis S van Etten, Jacobus F A Jansen, Louise van der Weerd, Heidi I L Jacobs, Walter H Backes, Susanne J van Velu. CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review. NeuroImage. Clinical. vol 28. 2021-06-25. PMID:33053497. |
by pooling data, we found that the prevalence of csf enhancement was 82% (95% confidence interval (ci) 80-89) in meningitis (4 studies, 65 patients), 73% (95%ci 62-81) in cases with (post-) acute intracerebral hemorrhage (2 studies, 77 cases), 64% (95% ci 54-73) in cases who underwent surgery for aneurysm treatment (2 studies, 99 patients), 40% (95% ci 30-51) in cases who underwent surgery for carotid artery disease treatment (3 studies, 76 patients), 27% (95% ci 25-30) in cases with acute ischemic stroke (9 studies, 1148 patients), 21% (95% ci 17-23) in multiple sclerosis (6 studies, 897 patients), and 13% (95% ci 7-21) in adult controls (4 studies, 112 cases). |
2021-06-25 |
2023-08-13 |
human |
Nazibrola Botchorishvili, Nino Shiukashvili, Nina Mikeladze, Ann Dzagnidze, Nino Mikava, Maia Tighashvili, Marina Janelidz. Screening of Cognitive Impairment in Patients with Multiple Sclerosis: A Cross-Sectional Study in Georgia. Neurology research international. vol 2021. 2021-06-19. PMID:34136283. |
cognitive impairment (ci) is a common symptom of multiple sclerosis (ms), with a significant negative impact on the occupational and social functioning of patients. |
2021-06-19 |
2023-08-13 |
Not clear |
Marta Simone, Rosa Gemma Viterbo, Lucia Margari, Pietro Iaffaldan. A Randomized Computer-Assisted Rehabilitation Trial of Attention in Pediatric Multiple Sclerosis: A Post Hoc Analysis. Brain sciences. vol 11. issue 5. 2021-06-15. PMID:34069276. |
cognitive impairment (ci) is a remarkable feature in pediatric-onset multiple sclerosis (poms). |
2021-06-15 |
2023-08-13 |
Not clear |
S M Gómez-Moreno, M L Cuadrado, I Cruz-Orduña, E M Martínez-Acebes, R Gordo-Mañas, C Fernández-Pérez, R García-Ramo. Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis. Neurologia (Barcelona, Spain). 2021-05-27. PMID:31983477. |
the neuropsychological batteries traditionally used for the assessment of cognitive impairment (ci) in patients with multiple sclerosis are complex tests requiring a long time to administer. |
2021-05-27 |
2023-08-13 |
Not clear |
Ana Laura Hernández-Ledesma, Adriana Jheny Rodríguez-Méndez, Lilia Susana Gallardo-Vidal, Teresa García-Gasca, Julia María Alatorre-Cruz, Pablo García-Solís, Julián López Reyes, Juan Carlos Solís-Saín. Lipid profile: causal relationship on cognitive performance in multiple sclerosis? Molecular biology reports. vol 47. issue 12. 2021-05-19. PMID:33259011. |
despite the evidence of an elevated prevalence of ci in patients with multiple sclerosis (ms), it is not considered among standard clinical evaluations, due the lack of specialists and time required. |
2021-05-19 |
2023-08-13 |
Not clear |
Damiano Paolicelli, Alessia Manni, Antonio Iaffaldano, Giusy Tancredi, Katia Ricci, Eleonora Gentile, Rosa Gemma Viterbo, Silvia Giovanna Quitadamo, Marina de Tommaso, Maria Trojan. Magnetoencephalography and High-Density Electroencephalography Study of Acoustic Event Related Potentials in Early Stage of Multiple Sclerosis: A Pilot Study on Cognitive Impairment and Fatigue. Brain sciences. vol 11. issue 4. 2021-05-18. PMID:33918861. |
cognitive impairment (ci) is a common and disabling symptom of multiple sclerosis (ms) with a negative impact on daily living. |
2021-05-18 |
2023-08-13 |
Not clear |
Aditi Vian Varma-Doyle, Walter J Lukiw, Yuhai Zhao, Jesus Lovera, Deidre Devie. A hypothesis-generating scoping review of miRs identified in both multiple sclerosis and dementia, their protein targets, and miR signaling pathways. Journal of the neurological sciences. vol 420. 2021-05-14. PMID:33183778. |
cognitive impairment (ci) is a frequent complication affecting people with multiple sclerosis (ms). |
2021-05-14 |
2023-08-13 |
Not clear |
Artemios Artemiadis, Christos Bakirtzis, Andreas Chatzittofis, Constantinos Christodoulides, George Nikolaou, Marina Kleopatra Boziki, Nikolaos Grigoriadi. Brief international cognitive assessment for multiple sclerosis (BICAMS) cut-off scores for detecting cognitive impairment in multiple sclerosis. Multiple sclerosis and related disorders. vol 49. 2021-05-14. PMID:33465758. |
cognitive impairment (ci) affects 35-65% of multiple sclerosis (ms) patients. |
2021-05-14 |
2023-08-13 |
Not clear |
Artemios Artemiadis, Christos Bakirtzis, Andreas Chatzittofis, Constantinos Christodoulides, George Nikolaou, Marina Kleopatra Boziki, Nikolaos Grigoriadi. Brief international cognitive assessment for multiple sclerosis (BICAMS) cut-off scores for detecting cognitive impairment in multiple sclerosis. Multiple sclerosis and related disorders. vol 49. 2021-05-14. PMID:33465758. |
the brief international cognitive assessment for multiple sclerosis (bicams) has been proposed as a highly feasible and cost-effective tool for cognitive impairment (ci) screening in ms. |
2021-05-14 |
2023-08-13 |
Not clear |
Larissa Carla de Paula Gois, Luciana Ramalho Pimentel-Silva, Benito Pereira Damasceno, Alfredo Damascen. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage. Multiple sclerosis and related disorders. vol 48. 2021-05-14. PMID:33477004. |
cognitive impairment (ci) is present in all stages and subtypes of multiple sclerosis (ms). |
2021-05-14 |
2023-08-13 |
Not clear |
Axel Petzold, Sharon Y L Chua, Anthony P Khawaja, Pearse A Keane, Peng T Khaw, Charles Reisman, Baljean Dhillon, Nicholas G Strouthidis, Paul J Foster, Praveen J Pate. Retinal asymmetry in multiple sclerosis. Brain : a journal of neurology. vol 144. issue 1. 2021-04-20. PMID:33253371. |
the prevalence of multiple sclerosis was 0.0023 [95% confidence interval (ci) 0.00229-0.00231]. |
2021-04-20 |
2023-08-13 |
human |
Axel Petzold, Sharon Y L Chua, Anthony P Khawaja, Pearse A Keane, Peng T Khaw, Charles Reisman, Baljean Dhillon, Nicholas G Strouthidis, Paul J Foster, Praveen J Pate. Retinal asymmetry in multiple sclerosis. Brain : a journal of neurology. vol 144. issue 1. 2021-04-20. PMID:33253371. |
overall the discriminatory power of diagnosing multiple sclerosis with the iepd auroc curve (0.71, 95% ci 0.67-0.76) and iead (0.71, 95% ci 0.67-0.75) for the macular gcipl complex were significantly higher if compared to the macular ganglion cell complex iepd auroc curve (0.64, 95% ci 0.59-0.69, p = 0.0017); iead auroc curve (0.63, 95% ci 0.58-0.68, p < 0.0001) and macular rnfl iepd auroc curve (0.59, 95% ci 0.54-0.63, p < 0.0001); iead auroc curve (0.55, 95% ci 0.50-0.59, p < 0.0001). |
2021-04-20 |
2023-08-13 |
human |
Ángela Bernabéu-Sanz, Sandra Morales, Valery Naranjo, Ángel P Semper. Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients. Diagnostics (Basel, Switzerland). vol 11. issue 3. 2021-04-13. PMID:33807060. |
cognitive impairment (ci) is frequently present in multiple sclerosis patients. |
2021-04-13 |
2023-08-13 |
Not clear |
Ángela Bernabéu-Sanz, Sandra Morales, Valery Naranjo, Ángel P Semper. Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients. Diagnostics (Basel, Switzerland). vol 11. issue 3. 2021-04-13. PMID:33807060. |
in this study we investigated the contribution of gray and white matter in the ci observed in mildly disabled relapsing-remitting multiple sclerosis (rrms) patients. |
2021-04-13 |
2023-08-13 |
Not clear |